Abstract
Hepatocellular carcinoma (HCC) is a malignant tumor unresponsive to most current therapies. Small peptides, either synthetic or derived from natural proteins, are found promising in treating HCC. Herein, different types of small peptides and their associated mechanistic actions against tumors are discussed, postulating their use as alternative treatments for HCC.
Keywords: Protein peptide, liver cancer, diagnosis, therapy, hepatocellular carcinoma
Protein & Peptide Letters
Title: The Use of Small Peptides in the Diagnosis and Treatment of Hepatocellular Carcinoma
Volume: 16 Issue: 5
Author(s): Felice H. Tsang, Nikki P. Lee and John M. Luk
Affiliation:
Keywords: Protein peptide, liver cancer, diagnosis, therapy, hepatocellular carcinoma
Abstract: Hepatocellular carcinoma (HCC) is a malignant tumor unresponsive to most current therapies. Small peptides, either synthetic or derived from natural proteins, are found promising in treating HCC. Herein, different types of small peptides and their associated mechanistic actions against tumors are discussed, postulating their use as alternative treatments for HCC.
Export Options
About this article
Cite this article as:
Tsang H. Felice, Lee P. Nikki and Luk M. John, The Use of Small Peptides in the Diagnosis and Treatment of Hepatocellular Carcinoma, Protein & Peptide Letters 2009; 16 (5) . https://dx.doi.org/10.2174/092986609788167860
DOI https://dx.doi.org/10.2174/092986609788167860 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Fighting Tumor Cell Survival: Advances in the Design and Evaluation of Pim Inhibitors
Current Medicinal Chemistry Dendrimers and the Development of New Complex Nanomaterials for Biomedical Applications
Current Medicinal Chemistry MICA Molecules in Disease and Transplantation, a Double-Edged Sword?
Current Immunology Reviews (Discontinued) Chinese Medicine: A Novel Therapeutic Option for Pancreatic Cancer
Current Signal Transduction Therapy ROCK Inhibitors as Emerging Therapeutic Candidates for Sarcomas
Current Cancer Drug Targets Colorectal Cancer Classification and Survival Analysis Based on an Integrated RNA and DNA Molecular Signature
Current Bioinformatics Pharmacogenetics of Oxazaphosphorines and its Clinical Implications
Current Pharmacogenomics Anti-Angiogenic Agents and Cancer: Current Insights and Future Perspectives
Recent Patents on Anti-Cancer Drug Discovery Repositioning of RdRp Inhibitors Against HCV NS5B Polymerase Utilizing Structure-Based Molecular Docking
Combinatorial Chemistry & High Throughput Screening Targeted Alpha Therapy with 213Bi
Current Radiopharmaceuticals Outlook on Epigenetic Therapeutic Approaches for Treatment of Gastric Cancer
Current Cancer Drug Targets Direct Gene Expression Analysis
Current Pharmaceutical Biotechnology Coordinated Expression of Pax-5 and FAK1 in Metastasis
Anti-Cancer Agents in Medicinal Chemistry Journey Describing the Cytotoxic Potential of Withanolides: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil
Current Respiratory Medicine Reviews Targeted Radionuclide Therapy - An Overview
Current Radiopharmaceuticals Genetic Surgery - A Right Strategy to Attack Cancer
Current Gene Therapy Thioredoxin System Modulation by Plant and Fungal Secondary Metabolites
Current Medicinal Chemistry Development of Doxorubicin Quantification by Reductive Amination
Current Analytical Chemistry Drug Targets in Herpes Simplex and Epstein Barr Virus Infections
Infectious Disorders - Drug Targets